INTRAOPERATIVE ADMINISTRATION OF HIGH-DOSE APROTININ REDUCES HYPERFIBRINOLYSIS AND HYPERCOAGULABILITY AFTER CARDIOPULMONARY BYPASS (CPB) - A PLACEBO-CONTROLLED STUDY
C. Legnani et al., INTRAOPERATIVE ADMINISTRATION OF HIGH-DOSE APROTININ REDUCES HYPERFIBRINOLYSIS AND HYPERCOAGULABILITY AFTER CARDIOPULMONARY BYPASS (CPB) - A PLACEBO-CONTROLLED STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 985-985